The majority of patients with osteogenesis imperfecta (OI) have a mutation in COL1A1 or COL1A2. Whole gene deletions appear to be an infrequent cause of OI.
ABSTRACT
The majority of patients with osteogenesis imperfecta (OI) have a mutation in COL1A1 or COL1A2. Whole gene deletions appear to be an infrequent cause of OI.
Here we describe a 8-year-old female with OI, intellectual disability and behavioural problems caused by a 2.3Mb deletion of chromosome 17q21.33 containing COL1A1. This deletion was detected using array comparative genomic hybridization (aCGH), performed to identify a cause for her intellectual disability.
DLX3, DLX4, CA10, CACNA1G, ITGA3
and XYLT2 were also deleted and likely to be contributing to her phenotype.
This case provides further evidence that aCGH is an important test for children with OI when it is associated with additional features, such as intellectual or behavioural disability. With greater use of aCGH, the proportion of patients with atypical OI due to contiguous gene deletions or copy number variation elsewhere in the genome is likely to become clearer. This case also provides evidence that deletions in COL1A1 resulting in haploinsuffiency are pathogenic and that a contiguous gene deletion may modify the patient's phenotype.
KEYWORDS: Osteogenesis imperfecta; atypical; COL1A1 deletion; Array comparative genomic hydridization (aCGH)

INTRODUCTION
Osteogenesis imperfecta (OI) is an inherited cause of bone fragility. The majority of OI is dominantly inherited and in 85% of cases due to mutations in the COL1A1 or COL1A2 genes [Forlino and Marini 2016] . There have been reports of patients with 'atypical' presentations, with features that cannot be explained by OI, such as intellectual disability [Balasubramanian and others 2016] . Use of array comparative genomic hybridization (aCGH) technology in these patients has identified copy number variants, which explain the additional features, alongside pathogenic mutations in type 1 collagen [Balasubramanian and others 2016] .
There are reports of chromosomal deletions involving COL1A1 causing OI associated with intellectual and/or behavioural difficulties (Table 1) . These deletions have been detected using gene sequencing [Bardai and others 2016] 
MATERIALS AND METHODS
Clinical phenotype:
The female proband was born to non-consanguineous parents, White European parents. There was no family history of non-traumatic or multiple fractures.
Intra-uterine growth retardation was observed on scans in pregnancy, but the child was born at term with a birth weight of 3.29kg (25-50 th centile). Following birth, her oral intake was poor; aged 10 months, her weight had dropped to the 0.4 th centile.
Aged 17 months, the patient fell from a low bed and suffered a spiral fracture of her right tibia. Radiographs showed that her bones were osteopenic. On examination, she had dark blue sclerae, brachycephaly, ligamentous laxity, an umbilical hernia and barrel-shaped chest. There was clinical (and, later, radiographic) evidence of dentinogenesis imperfecta. Lateral spine radiograph showed minor changes in 2-3 vertebrae shape, but no definite wedging or flattening.
A clinical diagnosis of osteogenesis imperfecta (OI) was made and she remained under follow-up. She suffered fractures of her left clavicle aged 2 years, of her left thumb aged 4 years, right middle finger aged 6 years but no further fractures of major long bones. Aged 4 years, significant wedging (>25% loss of anterior height) of T6 vertebra was identified on routine screening and bisphosphonate treatment started. She was started on a standard dose of pamidronate, (12mg/kg/year in 4 divided doses). Medical treatment led to noticeable increase in her energy and activity levels. Pamidronate treatment was ongoing at her last clinical review, aged 8 years, although the dose has been halved following stepwise reductions since 6 years of age.
Developmentally, her gross motor skills were delayed: rolling at 13 months, sitting without support at 18 months and walking at 3 years of age. She still requires ankle-foot orthoses and supportive footwear. She has delayed speech development and feeding difficulties, requiring speech therapy. She had astigmatism and hypermetropia associated with a squint. Mild loss of hearing was identified on testing from the third year of life. She underwent an adeno-tonsillectomy aged 5 years with improved hearing. An MRI-scan undertaken prior to 18 months of age showed mild ventricular enlargement and sulcal widening.
On recent review at 8 years of age, her height was 122.2cm, weight 21.1kg
and OFC 51cm (all growth parameters at the 2 nd -9 th centile). Her sclerae were blueish grey in colour, she had thick eyebrows, down-slanting palpebral fissures, high forehead and bilaterally low set ears ( Figure 1 ). She was hypermobile with generalised muscle weakness. Her behavioural difficulties were more apparent at this age with food aversions, tantrums, poor sleep and disruptive behaviour. She was resistant to change, would scream and become highly agitated when asked to do something she did not want to. Her mother felt her behaviour was extreme; it was hard to reason with her and she did not respond well to standard behaviour management strategies. She was on melatonin for sleep. She had limited visual motor skills and motor coordination. Her perceptive and cognitive skills were also limited. Special schooling was being considered. She exhibited age-appropriate bathing but required support with toileting. She struggled with coordination and balance. A WISC-IV completed by the Clinical Psychologist indicated her Full Scale IQ fell below the 0.1 st centile confirming the diagnosis of 'Intellectual Disability'.
Genetic analyses:
Mutation analysis was performed at the age of 7 years by sequencing a custom designed panel of genes associated with OI (COL1A1, COL1A2, CRTAP, LEPRE1, PPIB, FKBP10, SP7, SERPINF1, SERPINH1, PLOD2, BMP1, TMEM38B, WNT1, . This testing did not identify any causal variants of interest.
Array comparative genomic hydridization (aCGH) was performed on genomic DNA using the GeneChip System 3000 platform and Affymetrix Cytoscan 750K
array. The array consists of 550,000 non-polymorphic probes and 200,000 single nucleotide polymorphisms. The result was confirmed using fluorescent in situ hybridization (FISH) using a probe for COL1A1. Analysis was based on NCBI Build 37.
RESULTS
Array CGH showed a 2.3Mb loss of chromosome 17q21.33 (47, 777, 153, 165) [Jeremias and others 2016] .
Our patient had evidence of dentinogenesis imperfecta. As previously suggested by Bardei and colleagues, this may be related to loss of DLX3 as opposed to COL1A1, as dentinogenesis imperfecta is not usually seen with haploinsufficiency of COL1A1 [Bardai and others 2016; Ben Amor and others 2013] .
Reduced expression of DLX3 may have similar effects to the dominant negative common mutation in trichodentoosseous syndrome. This hypothesis remains speculative however and is not supported by the observation that deletion of DLX3 is not consistently associated with dentinogenesis imperfecta in published cases (Table   1) Transcriptional factor DLX3 promotes the gene expression of enamel matrix proteins during amelogenesis. PLoS One 10(3):e0121288. 
TABLES
